SciELO - Scientific Electronic Library Online

 
vol.45 issue3Comparison of reproductive factors in 117 limited scleroderma and 72 rheumatoid arthritis patientsUse of anti-rheumatic drugs during pregnancy author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Reumatologia

Print version ISSN 0482-5004On-line version ISSN 1809-4570

Abstract

COSTA, Olívia Lúcia Nunes et al. Antiphospholipid antibodies in women with recurrent pregnancy loss: a case-control study. Rev. Bras. Reumatol. [online]. 2005, vol.45, n.3, pp.119-123. ISSN 0482-5004.  http://dx.doi.org/10.1590/S0482-50042005000300006.

OBJECTIVE: To determine the prevalence of antiphospholipid antibodies in women with pregnancy loss and verify if such antibodies represent a risk factor for pregnancy failure. METHODS: We performed a case-control study with 250 pregnant and non-pregnant women, seen at a public maternity between March of 2003 and June of 2004. The women were divided in two groups according to their obstetric past: 100 women with previous pregnancy loss, defined as the obstetric criteria of the antiphospholipid syndrome (cases) and 150 healthy women with record of two or more successful pregnancies (controls). Lupus anticoagulant was determined by aTTP and dRVVT tests. IgG and IgM anticardiolipin antibodies (aCL) were determined by a specific immunoassay (ELISA) and results were expressed as GPL or MPL units. RESULTS: Lupus anticoagulant was positive in 5% of the cases and 2% of the controls (p = 0.27). The IgG aCL antibodies were present in 18% of the cases and 8,7% of the controls (p = 0.028 ;OR = 2.3; IC 95% = 1-53) and IgM aCL in 5% of the cases and 1% of the controls (p = 0,21). CONCLUSIONS: Antiphospholipid antibodies were more prevalent in women with pregnancy loss (28%) than in general obstetric population (17%). Women with IgG aCL antibodies have higher chances of pregnancy loss.

Keywords : recurrent miscarriage; antiphospholipids antibodies; antiphospholipid syndrome.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License